Royalty Pharma (RPRX) Prepaid Assets (2019 - 2026)
Royalty Pharma (RPRX) reported Prepaid Assets of $10.2 million for Q1 2026, up 230.01% on a YoY basis from $3.1 million in Q1 2025, and up 47.41% sequentially from $6.9 million in Q4 2025.
Royalty Pharma (RPRX) Prepaid Assets (2019 - 2026) Analysis & Trends
Royalty Pharma (RPRX) has 8 years of Prepaid Assets data on file, last reported at $10.2 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 230.01% year-over-year to $10.2 million; the trailing twelve-month figure through Mar 2026 stood at $10.2 million (up 230.01% YoY), and the FY2025 full-year result was $6.9 million, up 64.63% from the prior year.
- Prepaid Assets grew to $10.2 million in Q1 2026, from $6.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $90.5 million in Q4 2022 to a low of $2.3 million in Q2 2024.
- A 5-year average of $20.0 million and a median of $5.5 million in 2025 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets soared 1265.1% in 2022 and sank 92.51% in 2023, its largest moves.
- Tracing RPRX's Prepaid Assets over 5 years: stood at $90.5 million in 2022, then slumped by 80.07% to $18.0 million in 2023, then tumbled by 76.79% to $4.2 million in 2024, then soared by 64.63% to $6.9 million in 2025, then jumped by 47.41% to $10.2 million in 2026.
- Business Quant data shows RPRX's Prepaid Assets at $10.2 million in Q1 2026, $6.9 million in Q4 2025, and $5.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Royalty Pharma | 25.78 Bn | 28.22 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.16 Mn |
| Dec 31, 2025 | 6.89 Mn |
| Sep 30, 2025 | 5.52 Mn |
| Jun 30, 2025 | 4.45 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Dec 31, 2024 | 4.19 Mn |
| Sep 30, 2024 | 4.97 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 5.01 Mn |
| Dec 31, 2023 | 18.04 Mn |
| Sep 30, 2023 | 6.78 Mn |
| Jun 30, 2023 | 10.22 Mn |
| Mar 31, 2023 | 4.57 Mn |
| Dec 31, 2022 | 90.52 Mn |
| Sep 30, 2022 | 90.52 Mn |
| Jun 30, 2022 | 67.12 Mn |
| Mar 31, 2022 | 5.39 Mn |
| Dec 31, 2021 | 6.63 Mn |
| Sep 30, 2021 | 8.95 Mn |
| Jun 30, 2021 | 12.10 Mn |